Cancer control and prevention by nutrition and epigenetic approaches

Antioxidants and Redox Signaling

Volumn 17, Issue 2, 2012, Pages 355-364

  Verma, Mukesh ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANACARDIC ACID; BETAINE; BIOTIN; BUTYRIC ACID; CAFFEIC ACID; CHOLINE; COPPER; COUMARIC ACID; CURCUMIN; CYANOCOBALAMIN; EPICATECHIN; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; FOLIC ACID; GENISTEIN; HESPERIDIN; HISTONE DEACETYLASE INHIBITOR; ISOTHIOCYANIC ACID; ISOTHIOCYANIC ACID DERIVATIVE; LYCOPENE; PHLORETIN; POLYPHENOL; RESVERATROL; RETINOL; SELENIUM; SIRTUIN; THIOL; TURMERIC; UNINDEXED DRUG; ZINC;

BIOTINYLATION; BROCCOLI; CANCER CONTROL; CANCER PREVENTION; CANCER RISK; CARBON METABOLISM; CASHEW NUT; CHROMATIN STRUCTURE; CINNAMON; COFFEE; COLON CANCER; DNA METHYLATION; EPIGENETICS; FOLIC ACID DEFICIENCY; GARLIC; GENE EXPRESSION; GENETIC REGULATION; GRAPE; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; MATERNAL NUTRITION; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRIENT; NUTRITION; PRIORITY JOURNAL; REVIEW; SOYBEAN; TEA;

ANIMALS; DIETARY SUPPLEMENTS; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS;

EID: 84862092064     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4388     Document Type: Review

References (89)

1. Anderson CM, Lopez F, Zimmer A, and Benoit JN. Placental insufficiency leads to developmental hypertension and mesenteric artery dysfunction in two generations of Sprague-Dawley rat offspring. Biol Reprod 74: 538-544, 2006. (Pubitemid 43271358)
2. Ballestar E and Esteller M. Epigenetic gene regulation in cancer. Adv Genet 61: 247-267, 2008.
3. Beumer JH and Tawbi H. Role of histone deacetylases and their inhibitors in cancer biology and treatment. Curr Clin Pharmacol 5: 196-208, 2010.
4. Bommareddy A, Arasada BL, Mathees DP, and Dwivedi C. Chemopreventive effects of dietary flaxseed on colon tumor development. Nutr Cancer 54: 216-222, 2006. (Pubitemid 44316304)
5. Bryzgunova OE, Morozkin ES, Yarmoschuk SV, Vlassov VV, and Laktionov PP. Methylation-specific sequencing of GSTP1 gene promoter in circulating/ extracellular DNA from blood and urine of healthy donors and prostate cancer patients. Ann N Y Acad Sci 1137: 222-225, 2008.
6. Carr DF, Whiteley G, Alfirevic A, and Pirmohamed M;FolATED study team. Investigation of inter-individual variability of the one-carbon folate pathway: a bioinformatic and genetic review. Pharmacogenomics J 9: 291-305, 2009.
7. Chang CM, Yu CC, Lu HT, Chou YF, and Huang RF. Folate deprivation promotes mitochondrial oxidative decay: DNA large deletions, cytochrome c oxidase dysfunction, membrane depolarization and superoxide overproduction in rat liver. Br J Nutr 97: 855-863, 2007.
8. Chen Y, Gelfond JA, McManus LM, and Shireman PK. Reproducibility of quantitative RT-PCR array in miRNA expression profiling and comparison with microarray analysis. BMC Genomics 10: 407, 2009.
9. Chobanian AV. Improved hypertension control: cause for some celebration. JAMA 303: 2082-2083, 2010.
10. Chobanian, AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT Jr., and Roccella EJ;Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute;and National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252, 2003. (Pubitemid 37553153)
11. Chou YF and Huang RF. Mitochondrial DNA deletions of blood lymphocytes as genetic markers of low folate-related mitochondrial genotoxicity in peripheral tissues. Eur J Nutr 48: 429-436, 2009.
12. CoppedèF. The complex relationship between folate/homocysteine metabolism and risk of Down syndrome. Mutat Res 682: 54-70, 2009.
13. Dammann RH, Kirsch S, Schagdarsurengin U, Dansranjavin T, Gradhand E, Schmitt WD, and Hauptmann S. Frequent aberrant methylation of the imprinted IGF2/H19 locus and LINE1 hypomethylation in ovarian carcinoma. Int J Oncol 36: 171-179, 2010.
14. Davis CD and Ross SA. Dietary components impact histone modifications and cancer risk. Nutr Rev 65: 88-94, 2007. (Pubitemid 351804383)
15. Davis CD, Uthus EO, and Finley JW. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. J Nutr 130: 2903-2909, 2000. (Pubitemid 32005315)
16. Dimri M, Bommi PV, Sahasrabuddhe AA, Khandekar JD, and Dimri GP. Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells. Carcinogenesis 31: 489-495, 2010.
17. Donkena KV, Yuan H, and Young CY. Vitamin Bs, one carbon metabolism and prostate cancer. Mini Rev Med Chem 10: 1385-1392, 2010.
18. Duthie SJ. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis 34: 101-109, 2011.
19. Elsheikh SE, Green AR, Rakha EA, Powe D G, Ahmed RA, Collins HM, Soria D, Garibaldi, JM, Paish CE, Ammar AA, Grainge MJ, Ball GR, Abdelghany MK, Martinez-Pomares L, Heery DM, and Ellis IO. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 69: 3802-3809, 2009.
20. Esteller M. Epigenetics in cancer. N Engl J Med 358: 1148-1159, 2008.
21. Feinberg AP. Genome-scale approaches to the epigenetics of common human disease. Virchows Arch 456: 13-21, 2010.
22. Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, Bonaldi T, Haydon C, Ropero S, Petrie K, Iyer NG, Pérez-Rosado A, Calvo E, Lopez JA, Cano A, Calasanz MJ, Colomer D, Piris MA, Ahn N, Imhof A, Caldas C, Jenuwein T, and Esteller M. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nat Genet 37: 391-400, 2005.
23. Fraga MF and Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet 23: 413-418, 2007. (Pubitemid 47088010)
24. Ganesan A, Nolan L, Crabb SJ, and Packham G. Epigenetic therapy: histone acetylation, DNA methylation and anticancer drug discovery. Curr Cancer Drug Targets 9: 963-981, 2009.
25. Garzon R, Calin GA, and Croce CM. MicroRNAs in cancer. Annu Rev Med 60: 167-179, 2009.
26. Gieni RS and Hendzel MJ. Polycomb group protein gene silencing, non-coding RNA, stem cells, and cancer. Biochem Cell Biol 87: 711-746, 2009.
27. Han CT, Schoene NW, and Lei KY. Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells. Am J Physiol Cell Physiol 297: C1188-C1199, 2009.
28. Heijmans BT, Tobi EW, Lumey LH, and Slagboom PE. The epigenome: archive of the prenatal environment. Epigenetics 4: 526-531, 2009.
29. Heijmans BT, Tobi EW, Stein AD, Putter H, Blauw GJ, Susser ES, Slagboom PE, and Lumey LH. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci USA 105: 17046-17049, 2008.
30. Hong SK, Kim JH, Lin MF, and Park JI. The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells. Exp Cell Res 317: 2671-2682, 2011.
31. Jelinic P and Shaw P. Loss of imprinting and cancer. J Pathol 211: 261-268, 2007. (Pubitemid 46172701)
32. Johnson IT and Belshaw NJ. Environment, diet and CpG island methylation: epigenetic signals in gastrointestinal neoplasia. Food Chem Toxicol 46: 1346-1359, 2008. (Pubitemid 351258207)
33. Jones A and Wang H. Polycomb repressive complex 2 in embryonic stem cells: an overview. Protein Cell 1: 1056-1062, 2010.
34. Keijer J, Bekkenkamp-Grovenstein M, Venema D, and Dommels YE. Bioactive food components, cancer cell growth limitation and reversal of glycolytic metabolism. Biochim Biophys Acta 1807: 697-706, 2011.
35. Kim KC, Friso S, and Choi SW. DNA methylation, an epigenetic mechanism connecting folate to healthy embryonic development and aging. J Nutr Biochem 20: 917-926, 2009.
36. Kim YS and Milner JA. Bioactive food components and cancer specific metabolomic profiles. J Biomed Biotech 2011;PMID 21113295 (In press).
37. Kovacheva VP, Davison JM, Mellott TJ, Rogers AE, Yang S, O'Brien MJ, and Blusztajn JK. Raising gestational choline intake alters gene expression in DMBA-evoked mammary tumors and prolongs survival. FASEB J 23: 1054-1063, 2009.
38. Ku G and McManus MT. Behind the scenes of a small RNA gene-silencing pathway. Hum Gene Ther 19: 17-26, 2008. (Pubitemid 351171379)
39. Kulkarni A, Chavan-Gautam P, Mehendale S, Yadav H, and Joshi S. Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol 30: 79-84, 2011.
40. Kumar D and Verma M. Methods in cancer epigenetics and epidemiology. Methods Mol Biol 471: 273-288, 2009.
41. Laird PW. Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genet 11: 191-203, 2010.
42. Lane AA and Chabner BA. Histone deacetylase inhibitors in cancer therapy. J Clin Oncol 27: 5459-5468, 2009.
43. Lara E, Mai A, Calvanese V, Altucci L, Lopez-Nieva P, Martinez-Chantar ML, Varela-Rey M, Rotili D, Nebbioso A, Ropero S, Montoya G, Oyarzabal J, Velasco S, Serrano M, Witt M, Villar-Garea A, Imhof A, Mato JM, Esteller M, and Fraga MF. Salermide, a sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene 28: 781-791, 2009.
44. Li Y, Wang Z, Kong D, Li R, Sarkar SH, and Sarkar FH. Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells. J Biol Chem 283: 27707-27716, 2008.
45. Li N, Ye M, Li Y, Yan Z, Butcher LM, Sun J, Han X, Chen Q, Zhang X, and Wang J. Whole genome DNA methylation analysis based on high throughput sequencing technology. Methods 52: 203-212, 2010.
46. Li Y, Zhu J, Tian G, Li N, Li Q, Ye M, Zheng H, Yu J, Wu H, Sun J, Zhang H, Chen Q, Luo R, Chen M, He Y, Jin X, Zhang Q, Yu C, Zhou G, Sun J, Huang Y, Zheng H, Cao H, Zhou X, Guo S, Hu X, Li X, Kristiansen K, Bolund L, Xu J, Wang W, Yang H, Wang J, Li R, Beck S, Wang J, and Zhang X. The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol 8: e1000533, 2010.
47. Lin YW, Chen HM, and Fang JY. Gene silencing by the Polycomb group proteins and associations with cancer. Cancer Invest 29: 187-195, 2011.
48. Link A, Balaguer F, and Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 80: 1771-1792, 2010.
49. Lopatina NG, Vanyushin BF, Cronin GM, and Poirier LA. Elevated expression and altered pattern of activity of DNA methyltransferase in liver tumors of rats fed methyl-deficient diets. Carcinogenesis 19: 1777-1781, 1998. (Pubitemid 28474641)
50. Lustberg MB and Ramaswamy B. Epigenetic targeting in breast cancer: therapeutic impact and future direction. Drug News Perspect 22: 369-381, 2009.
51. Ma X, Ezzeldin HH, and Diasio RB. Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 69: 1911-1934, 2009.
52. Marik R, Allu M, Anchoori R, Stearns V, Umbricht CB, and Khan S. Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer. Cancer Biol Ther 11: 883-892, 2011.
53. Marson CM. Histone deacetylase inhibitors: design, structureactivity relationships and therapeutic implications for cancer. Anticancer Agents Med Chem 9: 661-692, 2009.
54. Matsuoka T, Adair JE, Lih FB, Hsi LC, Rubino M, Eling TE, Tomer KB, Yashiro M, Hirakawa K, Olden K, and Roberts JD. Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice.Br J Cancer 103: 1182-1191, 2010.
55. Meeran SM, Ahmed A, and Tollefsbol TO. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin Epigenetics 1: 101-116, 2010.
56. Millis RM. Epigenetics and hypertension. Curr Hypertens Rep 13: 21-28, 2011.
57. Milner JA. Nutrition and cancer: essential elements for a roadmap. Cancer Lett 269: 189-198, 2008.
58. Nafee TM, Farrell WE, Carroll WD, Fryer AA, and Ismail KM. Epigenetic control of fetal gene expression. BJOG 115: 158-168, 2008. (Pubitemid 350233604)
59. Pitchakarn P, Suzuki S, Ogawa K, Pompimon W, Takahashi S, Asamoto M, Limtrakul P, and Shirai T. Induction of G1 arrest and apoptosis in androgen-dependent human prostate cancer by Kuguacin J, a triterpenoid from Momordica charantia leaf. Cancer Lett 306: 142-150, 2011.
60. Piunti A and Pasini D. Epigenetic factors in cancer development: polycomb group proteins. Future Oncol 7: 57-75, 2011.
61. Plagemann A, Harder T, Brunn M, Harder A, Roepke K, Wittrock-Staar M, Ziska T, Schellong K, Rodekamp E, Melchior K, and Dudenhausen JW. Hypothalamic proopiomelanocortin promoter methylation becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome. J Physiol 587: 4963-4976, 2009.
62. Pogribny IP, Ross SA, Wise C, Pogribna M, Jones EA, Tryndyak VP, James SJ, Dragan YP, and Poirier LA. Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutat Res 593: 80-87, 2006. (Pubitemid 43113364)
63. Poirier LA. Methyl group deficiency in hepatocarcinogenesis. Drug Metab Rev 26: 185-199, 1994. (Pubitemid 24171628)
64. Powolny AA, Bommareddy A, Hahm ER, Normolle DP, Beumer JH, Nelson JB, and Singh SV. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J Natl Cancer Inst 103: 571-584, 2011.
65. Rodriguez RM and Fraga MF. Aging and cancer: are sirtuins the link? Future Oncol 6: 905-915, 2010.
66. Ross SA. Evidence for the relationship between diet and cancer. Exp Oncol 32: 137-142, 2010.
67. Ross SA, Dwyer J, Umar A, Kagan J, Verma M, Van Bemmel DM, and Dunn BK. Introduction: diet, epigenetic events and cancer prevention. Nutr Rev 66 Suppl 1: S1-S6, 2008.
68. Strakovsky RS, Zhou D, and Pan YX. A low-protein diet during gestation in rats activates the placental mammalian amino acid response pathway and programs the growth capacity of offspring. J Nutr 140: 2116-2120, 2010.
69. Szulwach KE, Li X, Smrt RD, Li Y, Luo Y, Lin L, Santistevan NJ, Li W, Zhao X, and Jin P. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol 189: 127-141, 2010.
70. Timp W, Levchenko A, and Feinberg AP. A new link between epigenetic progenitor lesions in cancer and the dynamics of signal transduction. Cell Cycle 8: 383-390, 2009.
71. Tobi EW, Heijmans BT, Kremer D, Putter H, Delemarre-van de Waal HA, Finken MJ, Wit JM, and Slagboom PE. DNA methylation of IGF2, GNASAS, INSIGF and LEP and being born small for gestational age. Epigenetics 6: 171-176, 2011.
72. Tobi EW, Lumey LH, Talens RP, Kremer D, Putter H, Stein AD, Slagboom PE, and Heijmans BT. DNA methylation differences after exposure to prenatal famine are common and timing-and sex-specific. Hum Mol Genet 18: 4046-4053, 2009.
73. Traka MH, Spinks CA, Doleman JF, Melchini A, Ball RY, Mills RD, and Mithen RF. The dietary isothiocyanate sulforaphane modulates gene expression and alternative gene splicing in a PTEN null preclinical murine model of prostate cancer. Mol Cancer 9: 189-194, 2010.
74. Ulrich CM. Folate and cancer prevention-where to next? Counterpoint. Cancer Epidemiol Biomarkers Prev 17: 2226-2230, 2008.
75. Vaquero A. The conserved role of sirtuins in chromatin regulation. Int J Dev Biol 53: 303-322, 2009.
76. Verma M. Viral genes and methylation. Ann N Y Acad Sci 983: 170-180, 2003. (Pubitemid 36399330)
77. Verma, M. The human epigenome and cancer. In: Human Genome Epidemiology, 2nd edition, edited by Khoury M, Bedrosian S, Gwinn M, Higgins J, Ioannidis J, and Little J. New York: Oxford University Press, 2010, pp. 551-578.
78. Verma M and Kumar D. Diagnosing cancer using histone analysis. In: Cancer Epigenetics, edited by Tollefsbol, T. New York: CRC Press, 2009, pp. 347-357.
79. Verma M, Maruvada P, and Srivastava S. Epigenetics and cancer. Crit Rev Clin Lab Sci 41: 585-607, 2004. (Pubitemid 39488775)
80. Verma M, Seminara D, Arena FJ, John C, Iwamoto K, and Hartmuller V. Genetic and epigenetic biomarkers in cancer: improving diagnosis, risk assessment, and disease stratification. Mol Diagn Ther 10: 1-15, 2006.
81. Villagra A, Sotomayor EM, and Seto E. Histone deacetylases and the immunological network: implications in cancer and inflammation. Oncogene 29: 157-173, 2010.
82. Vu TH, Nguyen AH, and Hoffman AR. Loss of IGF2 imprinting is associated with abrogation of long-range intrachromosomal interactions in human cancer cells. Hum Mol Genet 19: 901-919, 2010.
83. Wan SG, Taccioli C, Jiang Y, Chen H, Smalley KJ, Huang K, Liu XP, Farber JL, Croce CM, and Fong LY. Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression. Int J Cancer 129: 331-345, 2011.
84. Williams D, Verghese M, Walker LT, Boateng J, Shackelford L, and Chawan CB. Flax seed oil and flax seed meal reduce the formation of aberrant crypt foci (ACF) in azoxymethaneinduced colon cancer in Fisher 344 male rats. Food Chem Toxicol 45: 153-159, 2007. (Pubitemid 44803074)
85. Wu MY, Kuo CS, Lin CY, Lu CL, and Syu Huang RF. Lymphocytic mitochondrial DNA deletions, biochemical folate status and hepatocellular carcinoma susceptibility in a case-control study. Br J Nutr 102: 715-721, 2009.
86. Yan H, Zhu Y, Liu B, Wu H, Li Y, Wu X, Zhou Q, and Xu K. Mitogen-activated protein kinase mediates the apoptosis of highly metastatic human non-small cell lung cancer cells induced by isothiocyanates. Br J Nutr 23: 1-13, 2011.
87. Zeisel SH. Nutritional genomics: defining the dietary requirement and effects of choline. J Nutr 141: 531-534, 2011.
88. Zhang M, Liu X, and Holman CD. Effect of dietary intake of isoflavones on the estrogen and progesterone receptor status of breast cancer. Nutr Cancer 62: 765-773, 2010.
89. Zhao R, DeCoteau JF, Geyer CR, Gao M, Cui H, and Casson AG. Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues. Carcinogenesis 30: 2117-2122, 2009.